Jean-Yves Blay
EORTC, President

Jean-Yves Blay, MD, PhD, is Professor of Medicine in Medical Oncology and Head of the Medical Oncology Department at the Centre Leon Berard of the Université Claude Bernard in Lyon, France. Dr. Blay obtained his medical degree in 1990 specialising in oncology from the Université Claude Bernard in Lyon, France, and in 1994 he received his PhD, also from the Université Claude Bernard, for his... Read more

Françoise Meunier
EORTC, Director General

Françoise Meunier, Director General of the European Organisation for Research and Treatment of Cancer, received her medical degree from the Université Libre de Bruxelles (ULB) and completed her research fellowship at the Memorial Sloan-Kettering Cancer Center in New York in 1977-1978 (Fulbright award). She holds a Master’s Degree from the ULB in Medical Oncology (1976) and Internal Medicine,... Read more

Denis Lacombe
EORTC, Director

In 1988 Dr. Lacombe graduated as MD from the University of Marseilles (France). He was granted for a Master Post-doctoral Fellowship at the Roswell Park Cancer Institute, Buffalo, NY, USA for Fundamental and Clinical Pharmacokinetics from 1989-1991. From 1991 to 1993 he worked as Clinical Research Adviser in charge of the development of a new drug in oncology in the pharmaceutical industry. He... Read more

Yves Benoit

Yves Benoit, MD, PhD, is Professor of Medicine in Paediatric Hemato-Oncology and Head of the Departement of Paediatric Haemato-Oncology and Stemcell Transplantation at the Princess Elisabeth Children’s Hospital of the University Ghent, Belgium.
He obtained his medical degree in 1974 and started his speciality training in Pediatrics at Ghent University Hospital. He became involved in the... Read more

Jan Bogaerts

Jan Bogaerts earned his degree in mathematics (1986) and his PhD in mathematics (1993) at the Free University of Brussels (Belgium). In 1988 he also earned a degree in management at the Free University in Brussels. From 1986 to 1993 he worked as an assistant in mathematics and statistics at the faculties of Economic, Social and Political Sciences and of Science at Free University of Brussels.... Read more

Peter Donnelly

J Peter Donnelly is a microbiologist and coordinator of Studies in Supportive Care in the Department of Haematology at Radboud University Nijmegen Medical Centre, The Netherlands. After graduating with a BSc from Glasgow University, UK, he worked as a technician at Gartnavel General Hospital, Glasgow, gaining membership to the Institute of Biology and also fellowship to the Institute of... Read more

Ruxandra Draghia-Akli

Dr Ruxandra Draghia-Akli (MD, PhD) is Director of the Health Directorate at the Research DG of the European Commission. Previously, Ruxandra Draghia-Akli served as Vice President of Research at VGX Pharmaceuticals (now Inovio) and VGX Animal Health. Dr. Draghia’s research activities have focused on molecular biology, gene therapy and vaccination. She is recognised as a global leader in the... Read more

Alexander Eggermont

Alexander Eggermont is the Director General of the Cancer Institute Gustave Roussy, Villejuif-Paris, France. He is Professor of Surgical Oncology and Professor of International Networking in Cancer Research at the Erasmus University Medical Centre in Rotterdam. He holds the ‘Joseph Maisin Chair in Oncology at the Catholic University of Leuven in Belgium. In 1987 he obtained his PhD on ‘... Read more

Michel Goldman

Michel Goldman, Executive Director of IMI, builds and promotes networks of innovation, in close collaboration with all stakeholders involved in pharmaceutical R&D. IMI supports the launch and successful continuation of collaborative programmes to foster research and development activities on more effective and safer therapies for patients across Europe... Read more

Nadia Harbeck

Professor Nadia Harbeck is a full professor and head of the breast center at the University of Munich, Germany. She also heads the Oncological Therapy and Clinical Trials Unit at the University Dept. of OB&GYN in Munich. She received her Medical Degree from the University of Munich (LMU). From 2009-2011, she was head of the breast center at the University of Cologne. Until 2009, she was... Read more

Monika Hegi

Associate Professor for Translational and Experimental Neuro-Oncology
Monika Hegi completed her studies at the Federal Institute of Technology in Zurich (ETHZ) with a Doctorate in Natural Sciences with specialization in biochemistry and toxicology. She pursued her post-doctoral training in molecular toxicology and molecular carcinogenesis at the National Institute of Environmental Health... Read more

Michel Henry-Amar

Michel Henry-Amar, MD, PhD, is the Director of the “Cancéropôle Nord-Ouest Data Processing Centre (DPC)” at comprehensive cancer centre François Baclesse in Caen, France, and a member of the EORTC since 1970. Dr Henry-Amar’s research interests include the treatment of Hodgkin lymphoma in adults, cancer epidemiology, and study of long term complications of cancer treatments and their impact on... Read more

Jean-Claude Horiot

Jean-Claude Horiot witnessed and contributed nearly to half a century of research and progress in Radiation Oncolgy. Born in 1941, he was trained in Lyon (France) and then at the MD Anderson Hospital in Houston (Tx, USA). He was Professor of Radiation Oncology since 1972 at the University and Cancer Center GF Leclerc in Dijon (France) up until 2008 and is working since 2008 at the... Read more

Peter Kapitein

In the fight against cancer, both patients and their loved ones feel a huge sense of helplessness. Cancer is everywhere. Fighting seems pointless. One in three Dutch people develop cancer. Everyone involved has first-hand experience of how dramatically their lives are affected and how destructive it can be.
Inspire2Live was created to empower people to convert the sense of powerlessness... Read more

Sir Christopher Mallaby

Born in 1936, Christopher Mallaby studied Modern Languages and History at Cambridge University. He was in the British Diplomatic Service from 1959 to 1996. He was in the British Embassy in Moscow from 1961 to 1962 and from 1975 to 1977. He was in the British Mission in Berlin from 1966 to 1969 and the Embassy in Bonn from 1982 to 1985. He was head of Policy Planning in the Foreign Office from... Read more

Jean-Pierre Marie

Jean-Pierre Marie met hematology for the first time in 1976, as resident in Hôtel-Dieu hospital in Paris. Since this date, his career was devoted to onco-hematology. He spent 6 month in Mc Culloch lab in 1980, to learn leukemic cells culture, and came back to Hôtel-Dieu as Chef de Clinique, Associate professor and professor, in the department of his mentor, Prof Robert Zittoun, in Hôtel-Dieu... Read more

Martine J. Piccart

Martine J. Piccart, MD, PhD, is Professor of Oncology at the Université Libre de Bruxelles (ULB) and Director of Medicine at the Jules Bordet Institute, in Brussels, Belgium. Earning her medical degrees at the ULB and oncology qualifications in New York and London, she is also member of the Belgian Royal Academy of Medicine... Read more

Emiel Rutgers

PROF DR RUTGERS (1955) is a Surgical Oncologist at the Netherlands Cancer Institute in Amsterdam, Netherlands, Head of the Department of Surgery and Chair of the Institutes Breast Cancer Working Group. After earning a medical degree for the State University of Utrecht in the Netherlands, he completed his residency training in internal medicine at Sint Antonius Ziekenhuis, Utrecht, and his... Read more

Patrick Schöffski

Patrick Schöffski is Head of the Department of General Medical Oncology and of the Laboratory of Experimental Oncology at the University Hospitals Leuven, Catholic University Leuven, Belgium. For several years he served as Secretary of the Scientific Audit Committee of the Until October 2009, he was Secretary-General of the European Organisation for Research and Treatment of Cancer (EORTC). He... Read more

Lalitha Shankar

Lalitha K. Shankar, MD, PhD, is at the Cancer Imaging Program at the National Cancer Institute, at the National Institutes of Health in Bethesda, MD. Since joining NCI in 2002, she has served as an Advisor to the Associate Director of the Division of Cancer Treatment and Diagnosis. Her research interests have been both in the role of functional and molecular imaging in the diagnosis and... Read more

Roger Stupp

Department of Clinical Neurosciences and University of Lausanne, Lausanne, Switzerland. Roger Stupp, M.D. is head of the Department of Oncology-Hematology of the Riveria/Chablais region at the hospitals of Vevey and Monthey, Switzerland, and he serves as Attending Physician at the Department of Neurosurgery of University of Lausanne Medical Center (CHUV) where he leads the multidisciplinary... Read more

Koen Torfs

Koen Torfs is Vice President Health Economics, Market Access and Reimbursement for Europe, Middle East and Africa at Janssen, pharmaceutical companies of Johnson & Johnson.
Koen Torfs has a degree in political and social sciences from the Catholic University of Leuven and has extensive experience in health care economics in general and pharmaceutical economics in particular. Since... Read more

Galina Velikova

Professor of Psychosocial and Medical Oncology, University of Leeds / Honorary Consultant in Medical Oncology, Leeds Teaching Hospitals NHS Trust. Professor Velikova graduated from the Medical Institute, Varna, Bulgaria in 1986. She obtained a specialty degree in Internal Medicine in Bulgaria in 1994. Then she moved to UK and completed specialist training in Medical Oncology in 2001. She... Read more